SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.

Osaigbovo, II; Govender, NP; Jordan, AM; Bongomin, F; Meya, DB; Kanyua, A; Mashedi, OM; Koffi, D; Loyse, A; Sturny-Leclère, A; et al. Osaigbovo, II; Govender, NP; Jordan, AM; Bongomin, F; Meya, DB; Kanyua, A; Mashedi, OM; Koffi, D; Loyse, A; Sturny-Leclère, A; Gangneux, J-P; Denning, DW; Chiller, T; Cornely, OA; Oladele, RO (2024) The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa. Med Mycol, 62 (1). https://doi.org/10.1093/mmy/myad141. ISSN 1460-2709 https://doi.org/10.1093/mmy/myad141
SGUL Authors: Loyse, Angela

[img] Microsoft Word (.docx) Accepted Version
Restricted to Repository staff only until 28 December 2024.
Available under License ["licenses_description_publisher" not defined].

Download (47kB)

Abstract

On May 30th and 31st, 2023, delegates representing various African subregions, together with global representatives from the International Society of Human and Animal Mycology (ISHAM), the European Confederation of Medical Mycology (ECMM), the United States Centre for Disease Control and Prevention (CDC), and Global Action for Fungal Infections (GAFFI), convened in Nairobi, Kenya under the aegis of the Pan African Mycology Working Group, a working group of ISHAM. The meeting objectives were, amongst others, to deliberate on a continental response to the World Health Organisation Fungal Priority Pathogen List and facilitate interaction between global and regional leaders. Country delegates and international speakers addressed Africa's fungal disease burden; capacity for diagnosis and management; ongoing surveillance; knowledge gaps and trends in invasive fungal diseases such as Candida auris, mucormycosis, aspergillosis, and Acquired Immune Deficiency Syndrome (AIDS)-related mycoses; and current laboratory practice. During the technical sessions, expert panels deliberated on establishing and financing of national/regional surveillance networks for mycoses; establishing and sustaining African-led collaborations; expanding on existing laboratory and point-of-care diagnostic capacity as well as planning a mycology reference laboratory service and network in Africa. The meeting also highlighted successful African-led collaborations, capacity building, and clinical trial initiatives. The meeting conclusions informed the resolutions of the Nairobi Declaration calling for improved awareness; strong collaborations between clinical and laboratory teams across Africa; improved fungal disease surveillance within the continent; access to antifungals and diagnostics; and leveraging qualified human resources for mycology present within and outside Africa to facilitate trainings, collaborations, and exchanges.

Item Type: Article
Additional Information: This is a pre-copyedited, author-produced version of an article accepted for publication in Medical Mycology following peer review. The version of record Iriagbonse I Osaigbovo, Nelesh P Govender, Alexander M Jordan, Felix Bongomin, David B Meya, Alice Kanyua, Olga M Mashedi, David Koffi, Angela Loyse, Aude Sturny-Leclère, Jean-Pierre Gangneux, David W Denning, Tom Chiller, Oliver A Cornely, Rita O Oladele, The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa, Medical Mycology, Volume 62, Issue 1, January 2024, myad141 is available online at: https://doi.org/10.1093/mmy/myad141.
Keywords: Aspergillus, Candida, Africa, antifungal, laboratory, Humans, Kenya, Mycoses, Mucormycosis, Invasive Fungal Infections, Antifungal Agents, Humans, Mycoses, Mucormycosis, Antifungal Agents, Kenya, Invasive Fungal Infections, Africa, Aspergillus, Candida, laboratory, antifungal, 1108 Medical Microbiology, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Med Mycol
ISSN: 1460-2709
Language: eng
Dates:
DateEvent
9 January 2024Published
28 December 2023Published Online
27 December 2023Accepted
Publisher License: Publisher's own licence
PubMed ID: 38154488
Web of Science ID: WOS:001142251200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116149
Publisher's version: https://doi.org/10.1093/mmy/myad141

Actions (login required)

Edit Item Edit Item